sur Moderna, Inc. (NASDAQ:MRNA)
Moderna to Present at Piper Sandler's Healthcare Conference
Moderna, Inc. (Nasdaq: MRNA) has announced its participation in Piper Sandler's 37th Annual Healthcare Conference. The event will take place on December 2, 2025, at 11:00 am ET. Moderna will provide a live webcast of the presentation, available in the "Events and Presentations" section on the company's website. Following the presentation, the webcast will remain accessible for replay for at least 30 days.
The conference is a platform for Moderna to communicate advancements and strategies to investors. Moderna has been at the forefront of mRNA medicine development, significantly impacting the fields of infectious diseases and more. The company is recognized for its efficient development of COVID-19 vaccines among other therapeutics.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Moderna, Inc.